Newsfeeds - Spark Newswire

1 minute read

Why Co-Diagnostics Shares Are Trading Higher Today

Today, 4:09 PM

Co-Diagnostics Inc (NASDAQ: CODX) shares are trading higher Tuesday after the company announced its board authorized a share repurchase program, allowing Co-Diagnostics to repurchase up to $30 million of its common stock.

CODX

30 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 4:09 PM

During Tuesday's trading, 505 companies set new 52-week lows.

ACRX

19 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 4:09 PM

On Friday, 313 companies hit new 52-week lows.

AAON

2 minute read

News

Co-Diagnostics CoSara Receives Clearance From Indian Regulators For Hepatitis B Viral Load Test

By Benzinga Newsdesk

Today, 4:09 PM

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara

CODX

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 4:09 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABMD

1 minute read

Co-Diagnostics, Inc. JV CoSara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test

By Hal Lindon

Today, 4:09 PM

Co-Diagnostics, Inc.(NASDAQ: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd ("CoSara," or the "JV"), its joint venture for manufacturing and sales in India, has received clearance by the C

CODX

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 4:09 PM

ALNY

3 minute read

Co-Diagnostics, Inc. Signs Agreements With Idaho Molecular Inc And Advanced Conceptions, Inc., Pursuant To Which Each Will Become Wholly-Owned Subsidiaries Of Co.; Financial Terms Not Disclosed

By Bill Haddad

Today, 4:09 PM

CODX

2 minute read

18 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 4:09 PM

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.

ASRT

2 minute read

Co-Diagnostics’ Joint Venture, CoSara, Receives Clearance From Indian Regulators For ABC Multiplex Test

By Benzinga Newsdesk

Today, 4:09 PM

CODX